FOXO1 and neoplasm: In summary, our study fits the following working model: during lung tumorigenesis triggered by KrasG12D, Rbx1 collaborates with KrasG12D by promoting the ubiquitylation and degradation of tumor suppressors (e.g., p21 and Foxo1) as well as activating Mapk and mTorc pathways, leading to enhanced tumor progression.